Cardiac Ablation Ablation Market to Surpass USD 12.8 Bn as Pulsed Field Technology Replaces Traditional Methods

[Hyderabad, April 25th, 2025] — The global cardiac ablation systems market is projected to grow from USD 5.2 billion in 2023 to USD 12.8 billion by 2031 (12.1% CAGR), according to ClearView Market Insights. This 146% expansion is driven by pulsed field ablation (PFA) revolutionizing AFib treatment and robotic systems facilitating zero-fluoroscopy procedures.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-cardiac-ablation-systems-market/
Section 1: The Ablation Revolution
1.1 PFA’s Dominance
- Non-thermal safety: 1% complication rate vs 3-5% for RF
- Medicare Coverage: New Technology Add-on Payment (NTAP) for Farapulse™
1.2 Robotic Precision
- Stereotaxis Genesis:
- 0.1mm catheter control
- 45% less radiation exposure
Section 2: 2024 Market Shifts
2.1 AI Integration
System |
AI Function |
Outcome Improvement |
EnSite™ X |
Recurrence prediction |
89% accuracy |
Affera™ |
Real-time lesion assessment |
30% fewer repeat procedures |
2.2 Regulatory Milestones
- FDA’s 2024 PFA clearance: Covers persistent AFib
- EU MDR 2024: Mandates robotic safety protocols
Section 3: Future Roadmap
2024-2026:
- PFA captures 50% of new AFib cases.
- AI becomes standard in 80% of EP labs
2027-2031:
- 90% fluoroscopy-free procedures
- Ablation-as-prevention for high-risk patients
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369